Pharmanutra Statistics

Total Valuation

Pharmanutra has a market cap or net worth of EUR 484.96 million. The enterprise value is 480.14 million.

Market Cap	484.96M
Enterprise Value	480.14M

Important Dates

The next estimated earnings date is Monday, September 8, 2025.

Earnings Date	Sep 8, 2025
Ex-Dividend Date	May 5, 2025

Share Statistics

Pharmanutra has 9.60 million shares outstanding. The number of shares has decreased by -0.61% in one year.

Current Share Class	n/a
Shares Outstanding	9.60M
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.27%
Owned by Insiders (%)	10.77%
Owned by Institutions (%)	15.69%
Float	4.25M

Valuation Ratios

The trailing PE ratio is 29.22 and the forward PE ratio is 22.78.

PE Ratio	29.22
Forward PE	22.78
PS Ratio	4.18
PB Ratio	7.80
P/TBV Ratio	11.87
P/FCF Ratio	29.84
P/OCF Ratio	23.66
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.64, with an EV/FCF ratio of 29.55.

EV / Earnings	28.91
EV / Sales	4.13
EV / EBITDA	15.64
EV / EBIT	17.55
EV / FCF	29.55

Financial Position

The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.39.

Current Ratio	2.38
Quick Ratio	1.95
Debt / Equity	0.39
Debt / EBITDA	0.79
Debt / FCF	1.49
Interest Coverage	25.76

Financial Efficiency

Return on equity (ROE) is 28.39% and return on invested capital (ROIC) is 20.25%.

Return on Equity (ROE)	28.39%
Return on Assets (ROA)	14.88%
Return on Invested Capital (ROIC)	20.25%
Return on Capital Employed (ROCE)	30.36%
Revenue Per Employee	984,305
Profits Per Employee	140,754
Employee Count	118
Asset Turnover	1.01
Inventory Turnover	7.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.17% in the last 52 weeks. The beta is 0.32, so Pharmanutra's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-4.17%
50-Day Moving Average	51.99
200-Day Moving Average	52.90
Relative Strength Index (RSI)	50.39
Average Volume (20 Days)	8,425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmanutra had revenue of EUR 116.15 million and earned 16.61 million in profits. Earnings per share was 1.73.

Revenue	116.15M
Gross Profit	59.24M
Operating Income	27.36M
Pretax Income	27.16M
Net Income	16.61M
EBITDA	30.24M
EBIT	27.36M
Earnings Per Share (EPS)	1.73

Full Income Statement

Balance Sheet

The company has 29.10 million in cash and 24.27 million in debt, giving a net cash position of 4.83 million or 0.50 per share.

Cash & Cash Equivalents	29.10M
Total Debt	24.27M
Net Cash	4.83M
Net Cash Per Share	0.50
Equity (Book Value)	62.20M
Book Value Per Share	6.48
Working Capital	37.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 20.50 million and capital expenditures -4.25 million, giving a free cash flow of 16.25 million.

Operating Cash Flow	20.50M
Capital Expenditures	-4.25M
Free Cash Flow	16.25M
FCF Per Share	1.69

Full Cash Flow Statement

Margins

Gross margin is 51.00%, with operating and profit margins of 23.56% and 14.30%.

Gross Margin	51.00%
Operating Margin	23.56%
Pretax Margin	23.39%
Profit Margin	14.30%
EBITDA Margin	26.04%
EBIT Margin	23.56%
FCF Margin	13.99%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.98%.

Dividend Per Share	1.00
Dividend Yield	1.98%
Dividend Growth (YoY)	17.65%
Years of Dividend Growth	4
Payout Ratio	49.20%
Buyback Yield	0.61%
Shareholder Yield	2.59%
Earnings Yield	3.42%
FCF Yield	3.35%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pharmanutra has an Altman Z-Score of 7.99.

Altman Z-Score	7.99
Piotroski F-Score	n/a